Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Debt (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Non-Current Debt for 8 consecutive years, with $23290.0 as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Non-Current Debt fell 99.39% year-over-year to $23290.0, compared with a TTM value of $23290.0 through Jun 2017, down 99.39%, and an annual FY2016 reading of $159180.0, down 72.7% over the prior year.
  • Non-Current Debt was $23290.0 for Q2 2017 at Lisata Therapeutics, down from $215985.0 in the prior quarter.
  • Across five years, Non-Current Debt topped out at $15.0 million in Q3 2014 and bottomed at $23290.0 in Q2 2017.
  • Average Non-Current Debt over 5 years is $3.2 million, with a median of $698551.5 recorded in 2015.
  • The sharpest move saw Non-Current Debt soared 4206.64% in 2014, then plummeted 99.39% in 2017.
  • Year by year, Non-Current Debt stood at $531164.0 in 2013, then surged by 2515.08% to $13.9 million in 2014, then plummeted by 95.8% to $583041.0 in 2015, then plummeted by 72.7% to $159180.0 in 2016, then tumbled by 85.37% to $23290.0 in 2017.
  • Business Quant data shows Non-Current Debt for LSTA at $23290.0 in Q2 2017, $215985.0 in Q1 2017, and $159180.0 in Q4 2016.